Hospital
CHLB, LLC
CHLB, LLC was paid $3.23M by Medicaid between Jan 2018 and Nov 2024, across 102 billing codes. Its largest line is 0450, Emergency room services — 24% of everything it billed.
33Billing provider infoCHLB, LLC
LONG BEACH, CA 90806
LONG BEACH, CA 90806
33aNPI1215373626assigned 05/14/2013
33bProvider typePsychiatric Hospital Unit
28Total paid$3.23M
24GClaims150,859
24DCodes billed102
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Psychiatric Hospital Unit providers in California
Rank by total paid#12 of 33
Median peer was paid$361K
This provider vs. median9.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 28,193 | $806K | |
| 2019 | 20,539 | $438K | |
| 2020 | 17,457 | $382K | |
| 2021 | 20,337 | $421K | |
| 2022 | 22,482 | $486K | |
| 2023 | 22,208 | $404K | |
| 2024incomplete | 19,643 | $294K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 0450 | Emergency room services | 24% | 19,155 | 17,109 | $781K |
| 0915 | 9.9% | 1,532 | 134 | $319K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.2% | 6,463 | 5,983 | $266K |
| 70450 | Computed tomography, head or brain; without contrast material | 4.9% | 2,033 | 1,964 | $159K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 4.0% | 2,949 | 2,681 | $128K |
| 0360 | 3.0% | 815 | 784 | $96K | |
| 80053 | Comprehensive metabolic panel | 2.8% | 12,014 | 10,732 | $92K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.8% | 2,118 | 2,020 | $90K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.7% | 4,936 | 4,567 | $88K |
| 0270 | 2.5% | 5,078 | 4,464 | $81K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.4% | 1,046 | 1,009 | $79K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.4% | 2,992 | 2,785 | $78K |
90 more codes
| 99285 | Emergency room visit (most serious) | 2.4% | 739 | $77K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.3% | 2,119 | $75K |
| 99284 | Emergency room visit (serious) | 2.3% | 1,185 | $73K |
| 0301 | 2.2% | 1,423 | $72K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2.2% | 917 | $72K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 12,870 | $63K |
| 99199 | Unlisted special service, procedure or report | 1.6% | 1,251 | $53K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 4,185 | $40K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.2% | 729 | $37K |
| 83880 | 1.0% | 1,618 | $33K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,506 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,669 | $25K |
| 84484 | <1% | 3,725 | $25K | |
| 99283 | Emergency room visit (moderate) | <1% | 700 | $24K |
| 0250 | <1% | 2,188 | $23K | |
| 0710 | <1% | 1,001 | $20K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 401 | $19K |
| 83690 | <1% | 3,516 | $16K | |
| Z7502 | <1% | 436 | $15K | |
| J3490 | Unclassified drugs | <1% | 1,662 | $15K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,995 | $12K |
| 83605 | <1% | 1,550 | $11K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,458 | $10K |
| 87040 | <1% | 1,074 | $10K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 626 | $9K |
| 85730 | <1% | 1,823 | $7K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 56 | $7K |
| 85610 | <1% | 2,526 | $7K | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 18,267 | $6K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,193 | $6K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 152 | $5K |
| 84703 | <1% | 965 | $5K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,049 | $4K |
| 82962 | <1% | 2,536 | $4K | |
| 81001 | <1% | 1,606 | $4K | |
| A4217 | Sterile water/saline, 500 ml | <1% | 713 | $4K |
| 76377 | <1% | 37 | $4K | |
| 0914 | <1% | 89 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 904 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 297 | $3K |
| 83735 | <1% | 650 | $3K | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 384 | $2K |
| 81003 | <1% | 1,179 | $2K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 179 | $2K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 44 | $2K |
| J2060 | Injection, lorazepam, 2 mg | <1% | 494 | $2K |
| A0429 | Emergency ambulance ride, basic life support | <1% | 66 | $2K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 14 | $2K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 187 | $2K |
| 94644 | <1% | 109 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 332 | $2K |
| Z7506 | <1% | 12 | $2K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 154 | $1K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 39 | $1K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 239 | $1K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 76 | $1K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 13 | $969.83 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | <1% | 52 | $902.61 |
| 87077 | <1% | 243 | $896.98 | |
| 82550 | <1% | 208 | $869.96 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 138 | $790.98 |
| 81025 | <1% | 220 | $680.57 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 123 | $646.74 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 131 | $643.57 |
| 87186 | <1% | 150 | $632.86 | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 25 | $630.00 |
| 80320 | <1% | 165 | $623.50 | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $600.00 |
| 0320 | <1% | 53 | $592.45 | |
| 81015 | <1% | 236 | $590.17 | |
| 82150 | <1% | 101 | $548.61 | |
| 85378 | <1% | 116 | $541.87 | |
| 88312 | <1% | 52 | $444.07 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 117 | $388.47 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 26 | $343.28 |
| 82553 | <1% | 43 | $330.85 | |
| Z7512 | <1% | 12 | $313.56 | |
| 90715 | <1% | 13 | $243.25 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 41 | $200.92 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 42 | $195.05 |
| 73562 | <1% | 16 | $185.20 | |
| 36410 | <1% | 150 | $175.42 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 14 | $83.00 |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 131 | $52.87 |
| 80329 | <1% | 38 | $40.29 | |
| 86901 | <1% | 26 | $39.24 | |
| 86900 | <1% | 27 | $34.46 | |
| 0760 | <1% | 32 | $34.10 | |
| 0258 | <1% | 27 | $27.80 | |
| 0305 | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialWEISS, BARRY (MANAGER)
| Provider | Location | Paid |
|---|---|---|
| Community Home Care Referral Service, INC. | Brooklyn, NY | $528.00M |
| Community Home Care Referral Service INC. | Brooklyn, NY | $69.55M |
| Ocean Front Day Care LLC | Rockaway Park, NY | $1.30M |
| CHCM, INC. | Costa Mesa, CA | $60K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.